The tweet was deleted by the author.
But we saved everything 🙂.
Brandon Beylo reports on an unusual occurrence in the micro cap sector, where a company has suspended all biotech research and development operations to transform into a copper explorer in Morocco.
This dramatic shift in business strategy highlights the unpredictable nature of some micro cap firms, as described by Beylo.
Beylo has recently flagged changing trends in the sector, such as the acquisition of Crinetics Pharma by Vertex Pharma at a 100 percent premium. He also noted the potential for further declines in gold, suggesting it could drop to $3,800 per ounce before recovering. These observations reflect shifting conditions across both biotech and commodities.